Eli Lilly's experimental oral pill, orforglipron, shows promise in obesity treatment, with participants experiencing an average 12% body weight loss in a Phase 3 trial. The study, involving overweight or obese adults, revealed significant weight reduction and improved cardiovascular markers.
source https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/eli-lillys-daily-glp-1-pill-shows-strong-weight-loss-results-without-food-restrictions/articleshow/123240892.cms
India's ever-evolving narrative reflects a nation of growth, diversity, and aspirations. The economy is steadily advancing with strategic investments in technology and sustainability, emphasizing renewable energy and digital innovation. Politically, the Lok Sabha election campaigns are gaining momentum, with leaders promising reforms and development to address pressing issues. Socially, celebrations like Republic Day demonstrate the unity and pride of a culturally rich nation. Meanwhile, Indian athletes continue to inspire, with their remarkable performances on international platforms bringing laurels to the country. These developments highlight India's journey toward becoming a global powerhouse while staying rooted in its vibrant traditions. 
